entinostat has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with refractory solid tumors and lymphoid malignancies were treated with oral MS-275 on a once weekly schedule for 4 weeks of a 6-week cycle." | 2.73 | Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies. ( Chen, A; Chung, EJ; Conley, B; Donovan, E; Doroshow, JH; Figg, WD; Gardner, ER; Gutierrez, M; Hwang, K; Kalnitskiy, M; Kummar, S; Lee, MJ; Maynard, K; Melillo, G; Murgo, AJ; Ryan, QC; Trepel, JB; Zwiebel, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jóna, A | 1 |
| Khaskhely, N | 1 |
| Buglio, D | 1 |
| Shafer, JA | 1 |
| Derenzini, E | 1 |
| Bollard, CM | 1 |
| Medeiros, LJ | 1 |
| Illés, A | 1 |
| Ji, Y | 1 |
| Younes, A | 1 |
| Kummar, S | 1 |
| Gutierrez, M | 1 |
| Gardner, ER | 1 |
| Donovan, E | 1 |
| Hwang, K | 1 |
| Chung, EJ | 1 |
| Lee, MJ | 1 |
| Maynard, K | 1 |
| Kalnitskiy, M | 1 |
| Chen, A | 1 |
| Melillo, G | 1 |
| Ryan, QC | 1 |
| Conley, B | 1 |
| Figg, WD | 1 |
| Trepel, JB | 1 |
| Zwiebel, J | 1 |
| Doroshow, JH | 1 |
| Murgo, AJ | 1 |
1 trial available for entinostat and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Drug Administration Schedule; Enzyme Inhibitors; Fem | 2007 |
1 other study available for entinostat and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors.
Topics: Acetylation; Apoptosis; Apoptosis Regulatory Proteins; Benzamides; Biphenyl Compounds; Boronic Acids | 2011 |